Advanced Solid Tumors: DS-2243a Treatment

We are testing a new drug called DS-2243a in people with advanced solid tumors. This study aims to see how safe it is and how well it works compared to existing treatments.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
UZ Leuven
Medical oncology
Heverlee, Belgium
Centre Leon Berard
Cancérologie médicale
Meyzieu, France
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
Clinical Research Unit, Department of Medical Oncology
Amstelveen, Netherlands
Sponsor: Daiichi Sankyo Inc.
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.